B cell receptor silencing reveals the origin of high-grade B cell lymphomas with <i>MYC</i> and <i>BCL2</i> rearrangementsPaola Sindaco, Stefano Casola, Hadas Neuman et al.|bioRxiv (Cold Spring Harbor Laboratory)|2024Cited by 1
IMMUNOGLOBULIN CLASS DICTATES TRANSFORMATION TRAJECTORY AND BCR STATUS OF MYC/BCL2 DOUBLE‐HIT LYMPHOMA: BIOLOGY AND CLINICAL IMPLICATIONSStefano Casola, Fabio Facchetti, Paola Sindaco et al.|Hematological Oncology|2023Cited by 0
B Cell Receptor Silencing Reveals Origin and Impacts Treatment of High-Grade B Cell Lymphomas with <i>MYC</i> and <i>BCL2</i> RearrangementsStefano Casola, Fabio Facchetti, Paola Sindaco et al.|Blood|2024Cited by 0